For over two decades, Innovaderm has been the leading dermatology CRO and one of the largest dermatology Clinical Research Units (CRU) in North America. As we continue to grow and support immune-mediated diseases—including those in rheumatology, a therapeutic area inextricably linked to dermatology—we have rebranded the CRO side of our business to Indero. Our CRU will retain the name Innovaderm and will continue to conduct dermatology studies.